Practice Trends in OnabotulinumtoxinA and Augmentation Cystoplasty: Implications for Adult and Pediatric Urology
Since its approval for intradetrusor use, OnabotA has been increasingly adopted by pediatric and adult urologists, although with different trends suggesting unique applications of OnabotA. Among adult urologists, AC volumes declined but persisted, underscoring its continued role as a niche procedure for complex or refractory cases. OnabotA may complement, rather than replace, AC in the management of refractory bladder dysfunction.
Authors
- Christina Sze (ORCID: https://orcid.org/0000-0002-9891-8906)
- Ramy Goueli (ORCID: https://orcid.org/0000-0002-1677-5279)
- Derek Tran
- Zorawar Singh (ORCID: https://orcid.org/0000-0001-5138-9739)
- C. Fernández
- Gary E. Lemack
- Maali LaFrance
Institutions
- Hofstra University (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1097/upj.0000000000000898
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00